These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 17178132
1. Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists. Mannoury la Cour C, Vidal S, Pasteau V, Cussac D, Millan MJ. Neuropharmacology; 2007 Mar; 52(3):1003-14. PubMed ID: 17178132 [Abstract] [Full Text] [Related]
2. Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes. Mannoury la Cour C, Herbelles C, Pasteau V, de Nanteuil G, Millan MJ. J Neurochem; 2008 Apr; 105(2):308-23. PubMed ID: 18021295 [Abstract] [Full Text] [Related]
3. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes. Odagaki Y, Toyoshima R. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659 [Abstract] [Full Text] [Related]
4. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Wang HY, Undie AS, Friedman E. Mol Pharmacol; 1995 Dec 30; 48(6):988-94. PubMed ID: 8848015 [Abstract] [Full Text] [Related]
5. Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapine. Cussac D, Pasteau V, Millan MJ. Eur J Pharmacol; 2004 Feb 06; 485(1-3):111-7. PubMed ID: 14757130 [Abstract] [Full Text] [Related]
6. Dopamine-induced functional activation of Gαq mediated by dopamine D1-like receptor in rat cerebral cortical membranes. Odagaki Y, Kinoshita M, Ota T. J Recept Signal Transduct Res; 2019 Feb 06; 39(1):9-17. PubMed ID: 31223051 [Abstract] [Full Text] [Related]
7. Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions. Jin LQ, Wang HY, Friedman E. J Neurochem; 2001 Sep 06; 78(5):981-90. PubMed ID: 11553672 [Abstract] [Full Text] [Related]
8. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole. Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL. J Pharmacol Exp Ther; 2004 Jun 06; 309(3):903-20. PubMed ID: 14978194 [Abstract] [Full Text] [Related]
9. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain. Sóvágó J, Makkai B, Gulyás B, Hall H. Eur J Neurosci; 2005 Jul 06; 22(1):65-71. PubMed ID: 16029196 [Abstract] [Full Text] [Related]
10. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling. Jordan S, Johnson JL, Regardie K, Chen R, Koprivica V, Tadori Y, Kambayashi J, Kitagawa H, Kikuchi T. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):348-56. PubMed ID: 17070976 [Abstract] [Full Text] [Related]
11. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626. Millan MJ, Gobert A, Newman-Tancredi A, Lejeune F, Cussac D, Rivet JM, Audinot V, Dubuffet T, Lavielle G. J Pharmacol Exp Ther; 2000 Jun 30; 293(3):1048-62. PubMed ID: 10869410 [Abstract] [Full Text] [Related]
13. Action of novel antipsychotics at human dopamine D3 receptors coupled to G protein and ERK1/2 activation. Bruins Slot LA, Palmier C, Tardif S, Cussac D. Neuropharmacology; 2007 Aug 30; 53(2):232-41. PubMed ID: 17588617 [Abstract] [Full Text] [Related]
14. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function. Heidenreich BA, Mitrovic I, Battaglia G, Napier TC. Exp Neurol; 2004 Apr 30; 186(2):145-57. PubMed ID: 15026253 [Abstract] [Full Text] [Related]
15. Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum. Cai G, Wang HY, Friedman E. J Pharmacol Exp Ther; 2002 Sep 30; 302(3):1105-12. PubMed ID: 12183669 [Abstract] [Full Text] [Related]
16. SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain. Jin LQ, Goswami S, Cai G, Zhen X, Friedman E. J Neurochem; 2003 Apr 30; 85(2):378-86. PubMed ID: 12675914 [Abstract] [Full Text] [Related]
17. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors. Schwendt M, Gold SJ, McGinty JF. J Neurochem; 2006 Mar 30; 96(6):1606-15. PubMed ID: 16539683 [Abstract] [Full Text] [Related]
18. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist. Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC. Synapse; 2006 Dec 15; 60(8):599-608. PubMed ID: 17001660 [Abstract] [Full Text] [Related]